Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Bipolar Disorder and Role of Lithium in its Management: An overview


Affiliations
1 Government College of Pharmacy, Karad, Dist-Satara, Maharashtra - 415124, India
2 Govt. College of Pharmacy, Karad, Dist- Satara (Maharashtra), India- 415124, India
     

   Subscribe/Renew Journal


Bipolar disorder (BD) is a mental condition that usually involves extreme mood swings in human beings from conditions of excitement and feels happy at one moment to depression the next. It is usually associated with mental mania disorder characterized by great excitement and occasional uncontrolled violent behavior. Depression is characterized by persistent and long-term sadness or despair. Generally mental illnesses are due to result of several factors working together and can be divided into biological and psychological causes in case of BD. Compared to mania phase of persons suffering from BD, the depressive phase is often very severe and development of suicidal tendencies is a major risk factor. In fact, people suffering from BD are more likely to attempt suicide than those suffering from regular depression. Lithium (Li) has been the first choice for years for the treatment of BD and effectiveness is maximized when serum concentrations are maintained at 1.0-1.2 mEq/L. Li has long been used to reduce suicide risks. Recent studies have shown Li may also be effective in treatment against AIDS and cancer. The present review deals with the pathophysiology, types of BD and role of miracle drug Li in its management.

Keywords

Bipolar Disorder, Mania, Lithium.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Understanding Bipolar Disorder: Signs, symptoms, and causes of manic depression, (Downloaded from) http://www.helpguide.org/mental/bipolar_disorder_symptom s_treatment.htm#authors.

  • Helms RA,. Quran DJ. Drug & Disease Management. Textbook of Therapeutics.1999;1416-1426.

  • http://www.nmh.gov.tw/nmh_web/english_version/exhibition /exhibition_s0703.cfm.

  • Dening T.R.Evidence for the existence of schizophrenia in medieval Islamic society. History of Psychiatry, 1996;7: 55- 62. Cade J.F. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 1949; 2 (10): 349-52.

  • Sullivan PF, Pedersen NL. Mania in the Swedish Twin Registry: criterion validity and prevalence. Australian and New Zealand of Psychiatry, 2005; 39 (4): 235-43.

  • Lewis L,Hagop S. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. Journal of Affective Disorders. 2003;73 (1-2): 123-31.

  • Merikangas KR. Akiskal HS, Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch Gen Psychiatry.2007; 64(5):543-52.

  • American Psychiatric Association: Diagnostic & Statistical Manual of Mental Disorders,Text Revision. Washington, DC: American Psychiatric Association, 2000.

  • Schatzberg AF, Bipolar disorder: recent issues in diagnosis & classification. J. Clin. Psychiatry. 1998; 59 (suppl6): 13- 19.

  • Janicak PG, Davis JM.Treatment with mood stabilizers. In: Janicak PG, Davis JM, Preskorn SH, Ayd FJ, eds. Principles & Practice of Psychotherapy, 2nd ed. Baltimore: Williams & Wilkins. 1997;403-473.

  • Roger S, Intyre MC. Bipolar Disorder: Defining Remission and Selecting Treatment. Psychiatric Times. 2006, Vol. XXIII, No.11.

  • NIMH: Bipolar Disorder (downloaded from) http://www.murrellcounselingservice.com/pubs/bipolar.htm)

  • Goodnick PJ.Mania: Clinical & Research Perspectives. Washington, DC: American Psychiatric Press. 1998.

  • Pato CN, Kenedy JL, Genetics of bipolar disorder. 2000; 2 (4): 33-41.

  • Durand VM., Barlow DH. Abnormal Psychology: An Introduction. Scarborough, Ontario: Wadsworth. 2000.

  • Soares JC, Mann JJ. The anatomy of mood disordersreview of structural neuroimaging Studies. Biological Psychiatry 1997; 41(1): 86-106.

  • Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. Journal of Psychiatric Research, 1997; 31(4): 393-432.

  • Nathon KI, Musselman, AF. Biology of mood disorders. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, 1995; 439-477.

  • Goodwin FK, Jamison KR, Manic-depressive illness. New York: Oxford University Press. 1990.

  • BIPOLAR DISORDER (downloaded from) http://www.faqs.org/health/Sick-V1/Bipolar-Disorder.html.

  • Bowden MD. Medscape Psychiatry & Mental Health eJournal 2(3), 1997.

  • Roger S, McIntyre MD, Joan K.Bipolar Disorder: Defining Remission and Selecting Treatment. Psychiatric Times, October 2006;(23), 11.

  • Sachs GS, Printz DJ, Kahn DA.. The expert consensus guideline Series: medication treatment of bipolar disorder 2000. Postgraduate Medicine, 2000; 1-104.

  • Sachs GS, Thase ME. Bipolar disorder therapeutics: maintenance treatment. Biological Psychiatry, 2000; 48(6): 573-81.

  • Huxley NA,. Parikh SV, Baldessarini RJ. Effectiveness of psychosocial treatments in bipolar Disorder: state of the evidence. Harvard Review of Psychiatry, 2000; 8(3): 126- 40.

  • Vainionpaa LK, Rattya J,Knip M..Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology, 1999; 45(4): 444-50.

  • Suppes T, Webb A, Paul B.Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American Journal of Psychiatry, 1999; 156(8): 1164- 9.

  • Sachs GS. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression New England Journal of Medicine, 2007;356:1711-1722.

  • Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press. 1990.

  • Sachs GS. Bipolar mood disorder: Practicalstrategies for acute & maintenance phase treatment. J Clin Psychopharmacol 1996; 16: 32S-47S.

  • Dubovsky SL., Buzan RD. Novel alternatives & supplements to lithium & anticonvulsants for bipolar affective disorder. J Clin Psychiatry 1997; 58: 224-242.

  • Stoll AL, Severus WE, Freeman MP. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebocontrolled trial. Archives of General Psychiatry.1999; 56(5): 407-12.

  • American Psychiatric Association. Practice guideline for treatment of patients with bipolar disorder [revision]. Am J. Psychiatry 159:1-50, 2002

  • Bowden CL. Key treatment studies of lithium in manicdepressive illness: efficacy & side effects. J Clin Psychiatry 1998; 59 : 13-19.

  • Rouillon F, Gorwood P. The use of lithium to augment antidepressant medication. J Clin Psychiatry 59 . 1998:32- 39.

  • Bowden. CL. Predictors of response to divalproex & lithium. J Clin Psychiatry 56, 1995; 25-30.

  • Tripathi KD. Essentials of Medical Pharmacology, 5Th Editions, Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, 2003; 414-418.

  • Amdisen A. Serum level monitoring & clinical pharmacokinetic of lithium. Clin Pharmacokinetic 1977;2:73- 92.

  • . Ward ME, Musa MN.Clinical pharmacokinetics of lithium. J Clin Pharmacol 1994;34:280-285.

  • A.J. Gelenberg, J.M. Kane, M.B. Keller, et al. Comparison of standard & low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 1989. 321:1489-1493.

  • M.A. Gutierrez, N.R, Walker Kramer BA. Evaluation of a new steady-state lithium prediction method. Lithium1991. 2:57-59.

  • T. Joseph Dipiro, L.Robert, et al. Pharmacotherapy: A pathophysiologic approach, fifth edition, McGraw-HILL Medical Publishing Division, 2002, 1265-1287.

  • Remington, The science & practice of Pharmacy. 20th edition. Lipincott Williams & Wilkins, 2000, 1432-1433.

  • Barar FSK, Essential of Pharmacotherapeutics, third edition, S. Chand & Company Ltd., New Delhi, 2000;148- 149.

  • Lithium salt. In: G.K.McEvoy, Litvak K, Welsh OH, et al, eds. AHFS. Drug Information 2001. Bethesda, MD: American society of Health - System Pharmacist, 2001; 2369-2377.

  • .Cohen LS, Friedman JM. Jefferson JW, A reevaluation of risk in utero exposure to lithium.1994; 271:146-150.

  • Llewellyn A., Stowe ZN, Strader JR. The use of lithium & management of women with bipolar disorder during pregnancy & lactation. J Clin Psychiatry 59, 1998;57-64.

  • Larson R.Lithium Prevents Suicides. Insights on the News, 1998; 14 (18), 39.

  • More Uses for "Miracle Drug," Lithium, Sought in its 50th Year. (1999). Psychopharmacology Update, 10 (7), 1.


Abstract Views: 339

PDF Views: 2




  • Bipolar Disorder and Role of Lithium in its Management: An overview

Abstract Views: 339  |  PDF Views: 2

Authors

Nitin S. Chapekar
Government College of Pharmacy, Karad, Dist-Satara, Maharashtra - 415124, India
Sunil R. Bavaskar
Govt. College of Pharmacy, Karad, Dist- Satara (Maharashtra), India- 415124, India
Fahim J. Sayyad
Govt. College of Pharmacy, Karad, Dist- Satara (Maharashtra), India- 415124, India

Abstract


Bipolar disorder (BD) is a mental condition that usually involves extreme mood swings in human beings from conditions of excitement and feels happy at one moment to depression the next. It is usually associated with mental mania disorder characterized by great excitement and occasional uncontrolled violent behavior. Depression is characterized by persistent and long-term sadness or despair. Generally mental illnesses are due to result of several factors working together and can be divided into biological and psychological causes in case of BD. Compared to mania phase of persons suffering from BD, the depressive phase is often very severe and development of suicidal tendencies is a major risk factor. In fact, people suffering from BD are more likely to attempt suicide than those suffering from regular depression. Lithium (Li) has been the first choice for years for the treatment of BD and effectiveness is maximized when serum concentrations are maintained at 1.0-1.2 mEq/L. Li has long been used to reduce suicide risks. Recent studies have shown Li may also be effective in treatment against AIDS and cancer. The present review deals with the pathophysiology, types of BD and role of miracle drug Li in its management.

Keywords


Bipolar Disorder, Mania, Lithium.

References